# Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP

> **NCT04660084** · NA · TERMINATED · sponsor: **Haukeland University Hospital** · enrollment: 374 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DIAGNOSTIC_TEST:** Ultra-rapid molecular point-of-care testing

## Key facts

- **NCT ID:** NCT04660084
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-25
- **Primary completion:** 2022-06-21
- **Final completion:** 2022-06-21
- **Target enrollment:** 374 (ACTUAL)
- **Why stopped:** The trial was stopped earlier than planned after an ad hoc interim analysis
- **Last updated:** 2023-10-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04660084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04660084, "Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04660084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*